Health The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ABBV, LILM and IIPR June 2, 2022
Biotechnology Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive Disorder June 2, 2022
Health ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action – ABBV June 1, 2022
Biotechnology GBT to Host Investor Conference Call on Friday, June 10 and Participate in Upcoming Investor Conferences June 1, 2022
Search
Health
